Form4insider filings, from the source

SEC Form 4 · accession 0001012975-15-000053

Sage Therapeutics, Inc. · SAGE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mark J Levin
10% Owner
Period of report
Jan 16, 2015
Accepted (ET)
Jan 20, 2015 · 5:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Jan 16, 2015J652,758$0.00D11,028,250D
Common StockF4Jan 16, 2015J42,173$0.00A42,173D
Common StockF4Jan 16, 2015J42,173$0.00D0D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses